Volimark-M 0.3 Tablet is used in the treatment of type 2 diabetes mellitus. Diabetes mellitus is a metabolic disease that causes high blood sugar levels. It occurs when the insulin is resistant in breaking down glucose to produce energy (insulin resistance) or the pancreas (an organ behind the stomach) produces little or no insulin at all.

Volimark-M 0.3 Tablet contains Voglibose and Metformin. Voglibose acts by inhibiting the intestinal enzymes, which break complex sugars into simple sugars such as glucose. Metformin reduces serum glucose levels without increasing insulin secretion. It is also known as an insulin sensitiser as it increases the effects of insulin.

The common side effects of Volimark-M 0.3 Tablet include nausea, vomiting, changes in taste, diarrhoea, stomach pain, and loss of appetite. Most of these side effects do not require medical attention and typically resolve on their own over time. However, if the side effects persist or worsen, consult your doctor.

Do not take Volimark-M 0.3 Tablet if you are allergic to any of its components. Consult your doctor if you are pregnant or breastfeeding. The safety and effectiveness of Volimark-M 0.3 Tablet in children have not been established. Avoid consuming alcohol during treatment with Volimark-M 0.3 Tablet .

Volimark-M 0.3 Tablet is used in the treatment of type 2 diabetes mellitus. The detailed uses of Volimark-M 0.3 Tablet are as follows:

• Management of type 2 diabetes mellitus: Helps control high blood sugar levels in adults with type 2 diabetes.
• Improves insulin sensitivity: Metformin enhances the body's response to insulin and reduces glucose production by the liver.
• Delays glucose absorption: Voglibose reduces the breakdown and absorption of carbohydrates in the intestine, thereby avoiding post-meal sugar spikes.
• Reduces risk of diabetes complications: Volimark-M 0.3 Tablet helps reduce the risk of kidney damage, nerve disorders, and vision problems that can result from uncontrolled blood sugar levels.

• Take Volimark-M 0.3 Tablet with food to prevent stomach upset or as advised by your doctor.
• Follow your doctor's instructions on the dosage and timing of this medication to ensure safe and effective use.
• Swallow Volimark-M 0.3 Tablet as a whole with a glass of water.
• Do not crush, break, or chew it.

• Volimark-M 0.3 Tablet is used to treat type 2 diabetes mellitus. It is a combination of Voglibose and Metformin.
• Voglibose belongs to the class of alpha-glucosidase inhibitors. It delays glucose absorption by inhibiting the intestinal enzymes, which break complex sugars into simple sugars such as glucose. This process prevents the rise of blood glucose levels immediately after meals.
• Metformin belongs to the class of biguanides. It demonstrates the non-pancreatic effect of reducing serum glucose levels without increasing insulin secretion. It is also known as an insulin sensitiser as it increases the effects of insulin.

• Do not take Volimark-M 0.3 Tablet if you are allergic to any of its components.
• Inform the doctor if you have acute metabolic acidosis, severe renal failure, alcoholism, acute alcoholic intoxication, liver problems, diabetic pre-coma, severe infections, trauma, gastrointestinal obstruction, heart problems or if you are due to undergo any surgery.
• Consult your doctor if you are pregnant or breastfeeding.
• Avoid consuming excessive alcohol, as it can potentiate lactic acidosis.
• Let the doctor know if you are taking any other medicines, including supplements or herbal products.
• This medicine may cause lactic acidosis (a rare, but serious metabolic complication of excess lactic acid in the blood that is caused by metformin accumulation). The risk of lactic acidosis is high in older people with kidney, liver, and heart diseases.